RPM 2.0 continuously and randomly changes theorientation of samples to create a space-like microgravity environment on Earth. 

First developed by Airbus more than 20 years ago, the technology was acquired by YURI in 2023, which has continued its development and supply eversince. 

A proven rotation-path algorithm allows users to set conditions ranging from microgravity (10⁻³ g) to Moon- and Mars-level partial gravity(up to 0.9 g), and its compact footprint means it runs directly inside astandard incubator.

With an extensive track record, RPM 2.0 is recognized as the global goldstandard in its field. It is used by more than 60 research groups worldwide,including NASA and the European Space Agency (ESA), and has supported both the preparation of International Space Station (ISS) experiments and post-flightcomparative analysis. Applications span cell biology, cancer research, 3D cellculture and organoids, tissue engineering, and microbial and plant research.The manufacturer, YURI, is a leader in space biotech with more than 30 years ofexperience and 11 ISS missions to its name.

Going beyond instrument supply, Tetra Biotech will work closely with the manufacturer to provide expert scientific support, including installation, training, experimental design consultation and technical documentation. Ourgoal is to help Korean researchers get the most out of a world-classmicrogravity research environment.